Data as of Sep 30, 2026, 6:36 AM
Trades Mar 31, 2023 – Mar 30, 2026
Issuer
3 politicians disclosed trades in GMAB (Genmab A/S) between Mar 31, 2023 – Mar 30, 2026.
Trades
10
Politicians
3
Buy vol.
$48.0k
Sell vol.
$32.0k
Sector
A sale may close the position; filings are not a live holdings snapshot.
| Name | Last trade | Buys | Sells | Est. volume |
|---|---|---|---|---|
| Alan Armstrong | Mar 30, 2026 | 1 | 0 | $8,001 |
| Name | Last trade | Buys | Sells | Est. volume |
|---|---|---|---|---|
| Josh Gottheimer | Jan 16, 2025 | 5 | 3 | $64.0k |
| Daniel Goldman | Mar 31, 2023 | 0 | 1 | $8,001 |
| Name | Last trade | Buys | Sells | Est. volume |
|---|---|---|---|---|
| Josh Gottheimer | Jan 16, 2025 | 5 | 3 | $64.0k |
| Daniel Goldman | Mar 31, 2023 | 0 | 1 | $8,001 |
| Name | Last trade | Buys | Sells | Est. volume |
|---|---|---|---|---|
| Alan Armstrong | Mar 30, 2026 | 1 | 0 | $8,001 |
| Politician | Traded issuer | Sector | Type | Size | Traded | Trade price | Yesterday | Published | Filed after |
|---|---|---|---|---|---|---|---|---|---|
| Alan Armstrong | Genmab A/SGMAB | Fixed income | Purchase | $1k–$15k | Mar 30, 2026 | $25.83 | $35.57 | Jul 21, 2026 | 113 days |
| Josh Gottheimer | Genmab A/SGMAB | Healthcare | Purchase | $1k–$15k | Jan 16, 2025 | $21.22 | $35.57 | Feb 10, 2025 | 25 days |
| Josh Gottheimer | Genmab A/SGMAB | Healthcare | Sale | $1k–$15k | Dec 16, 2024 | $20.02 | $35.57 | Jan 14, 2025 | 29 days |
| Josh Gottheimer | Genmab A/SGMAB | Healthcare | Purchase | $1k–$15k | Jul 19, 2024 | $27.75 | $35.57 | Aug 15, 2024 | 27 days |
| Josh Gottheimer | Genmab A/SGMAB | Healthcare | Sale | $1k–$15k | Jun 18, 2024 | $25.80 | $35.57 | Jul 9, 2024 | 21 days |
| Josh Gottheimer | Genmab A/SGMAB | Healthcare | Purchase | $1k–$15k | Oct 16, 2023 | $32.55 | $35.57 | Nov 11, 2023 | 26 days |
| Josh Gottheimer | Genmab A/SGMAB | Healthcare | Sale | $1k–$15k | Sep 15, 2023 | $37.98 | $35.57 | Oct 15, 2023 | 30 days |
| Josh Gottheimer | Genmab A/SGMAB | Healthcare | Purchase | $1k–$15k | Jul 20, 2023 | $41.45 | $35.57 | Aug 21, 2023 | 32 days |
| Josh Gottheimer | Genmab A/SGMAB | Healthcare | Purchase | $1k–$15k | Jul 19, 2023 | $40.90 | $35.57 | Aug 21, 2023 | 33 days |
| Daniel Goldman | Genmab A/SGMAB | Healthcare | Sale | $1k–$15k | Mar 31, 2023 | $37.76 | $35.57 | Apr 17, 2023 | 17 days |
Download GMAB congressional trades (CSV)Every politician who disclosed a trade in this symbol in the current snapshot.
RSS for GMABNew congressional filings in this symbol, by filing date.
Educated guesstimate only. Filings report ranges, not exact sizes. Share counts use the range midpoint (or 1.5× the floor for “Over $X”) and the closing price on the trade date. Open lots are marked to the latest Yahoo Finance close. Cash dividends and split factors are applied while a reconstructed lot is open. Sales with no matching disclosed buy are treated as closing an unseen lot at the sale price (about $0 P/L on that slice). Bonds and rows without a usable ticker are excluded. This is not actual profit.